The hiPSCs have been successfully used to create human models of diabetes caused by monogenic disorders that effect beta cell development and function such as in the Wolfram syndrome [160] and insulin gene mutations [161,162], but only recently researchers started to investigate the potential of hiPSCs in acquired forms of diabetes. The gene discussed is INS; the disease is diabetes mellitus.